This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Bravelle (2015-10-23)
- Starting date:
- October 23, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-55684
Affected Products
Bravelle
Reason
Out of specification result for potency during shelf life testing.
Depth of distribution
Clinics, hospitals and/or wholesalers in all provinces/territories
Affected products
Bravelle
DIN, NPN, DIN-HIM
DIN 02268140
Dosage form
Poudre lyophilisée stérile pour injection
Strength
Urofollitropin 75 IU
Lot or serial number
Lot H15940B
Lot H15940C
Lot K16990B
Lot K16990C
Companies
- Recalling Firm
-
Ferring Inc.
200 Yorkland Blvd., Suite 800,
North York
M2J 5C1
Ontario
CANADA
- Marketing Authorization Holder
-
Ferring Inc.
200 Yorkland Blvd., Suite 800,
North York
M2J 5C1
Ontario
CANADA